Pingfu Fu_crop

Pingfu Fu, PhD

Associate Professor

pxf16@case.edu | 216.368.3911 | School of Medicine, Wood Bldg. Rm. WG-82P

Education

Ph.D. 2001, Biostatistics; M.S. 1996, Statistics, Case Western Reserve University, Cleveland, Ohio
M.S. 1988, Mathematics, Xiangtan University, Xiangtan, Hunan, China
B.S. 1984, Mathematics, Jiangxi Normal University, Nanchang, Jiangxi, China

Personal Website: http://bfox.cwru.edu/~pxf

Research Interest

Survival analysis, study design, measurements with limits of detection, tree-based methods, problem of separation, clinical trials and novel applications of statistical methods to medical research, especially to cancer and HIV/AIDS.

Professional Memberships

American Statistical Association

Recent Publications

  1. Luo, Z, Li, Z, Martin, L, Wan, Z, Meissner, EG, Espinosa, E, Wu, H, Yu, X, Fu, P, Westerink, MAJ, Kilby, JM, Wu, J, Huang, L, Heath, SL, Li, Z, Jiang, W. Pathological role of anti-CD4 antibodies in HIV-infected immunologic non-responders under viral suppressive antiretroviral therapy. J. Infect. Dis. 2017; : . PubMed PMID:28498953 .
  2. Tacastacas, JD, Chan, DV, Carlson, S, Gerson, SL, Dowlati, A, Fu, P, Lu, K, Groft, S, Rosenjack, J, Honda, K, McCormick, TS, Cooper, KD. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial. JAMA Dermatol 2017; 153 (5): 413-420. PubMed PMID:28199478 .
  3. Soler, DC, Young, AE, Griffith, AD, Fu, PF, Cooper, KD, McCormick, TS, Popkin, DL. Overexpression of AQP3 and AQP10 in the skin exacerbates psoriasiform acanthosis. Exp. Dermatol. 2017; : . PubMed PMID:28111811 .
  4. Starr, AG, Caimi, PF, Fu, P, Massoud, MR, Meyerson, H, Hsi, ED, Mansur, DB, Cherian, S, Cooper, BW, De Lima, MJG, Lazarus, HM, Gerson, SL, Jagadeesh, D, Smith, MR, Dean, RM, Pohlman, BL, Hill, BT, William, BM. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era. Hematology 2017; : 1-7. PubMed PMID:28105889 .
  5. Massoud, MR, Caimi, PF, Ferrari, N, Fu, P, Creger, R, Fox, R, Carlson-Barko, J, Kolk, M, Brister, L, Cooper, BW, Gerson, S, Lazarus, HM, de Lima, M, William, BM. Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience. Rev Bras Hematol Hemoter ; 38 (4): 314-319. PubMed PMID:27863759 PubMed Central PMC5119668.
  6. Sakre, N, Wildey, G, Behtaj, M, Kresak, A, Yang, M, Fu, P, Dowlati, A. RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR. Oncotarget 2017; 8 (4): 5992-6002. PubMed PMID:27863413 PubMed Central PMC5351607.
  7. Oleinick, NL, Biswas, T, Patel, R, Tao, M, Patel, R, Weeks, L, Sharma, N, Dowlati, A, Gerson, SL, Fu, P, Zhang, J, Machtay, M. Radiosensitization of non-small-cell lung cancer cells and xenografts by the interactive effects of pemetrexed and methoxyamine. Radiother Oncol 2016; 121 (2): 335-341. PubMed PMID:27838149 .
  8. Norris, RE, Behtaj, M, Fu, P, Dowlati, A. Evaluating the role of phase I expansion cohorts in oncologic drug development. Invest New Drugs 2017; 35 (1): 108-114. PubMed PMID:27718038 .
  9. Starr, AG, Caimi, PF, Fu, P, Massoud, MR, Meyerson, H, Hsi, ED, Mansur, DB, Cherian, S, Cooper, BW, De Lima, MJ, Lazarus, HM, Gerson, SL, Jagadeesh, D, Smith, MR, Dean, RM, Pohlman, BL, Hill, BT, William, BM. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era. Br. J. Haematol. 2016; 175 (2): 275-280. PubMed PMID:27443247 .
  10. Starr, AG, Caimi, PF, Fu, P, Massoud, MR, Meyerson, H, Hsi, ED, Mansur, DB, Cherian, S, Singh, AD, Cooper, BW, De Lima, MJ, Lazarus, HM, Gerson, SL, Jagadeesh, D, Smith, MR, Dean, RM, Pohlman, BL, Hill, BT, William, BM. Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes. Br. J. Haematol. 2016; 173 (3): 404-12. PubMed PMID:26953041 .
Search PubMed